Skip to main content
Clinical Trials/IRCT20220713055465N2
IRCT20220713055465N2
Recruiting
Phase 2

Investigating the effect of probiotic supplementation compared to placebo on serum oxidative stress factors in patients with multiple sclerosis (MS)

Tabriz University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tabriz University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Definitive diagnosis of multiple sclerosis based on 2017 MacDonald criteria
  • Relapsing Remitting MS (RRMS)
  • Informed consent to participate in the study

Exclusion Criteria

  • The presence of other neurological diseases at the same time as MS
  • Diabetes mellitus (DM)
  • Other inflammatory diseases
  • Rheumatological diseases
  • Acute and chronic infectious diseases (including urinary tract infection)
  • Relapsing of the disease in the last 4 months
  • Receiving pulse coronet during the last 4 months
  • Progressive MS
  • CIS (Clinically isolated syndrome)
  • Literacy level below 12 years and lack of proficiency in Persian language

Outcomes

Primary Outcomes

Not specified

Similar Trials